The Relative Strength (RS) Rating for Houlihan Lokey Cl A entered a new percentile Tuesday, with an increase from 77 to 82.
IBD's proprietary rating measures share price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history shows that the market's biggest winners often have an RS Rating of above 80 as they launch their biggest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
Houlihan Lokey Cl A is now considered extended and out of buy range after clearing a 137.92 buy point in a first-stage flat base. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Top and bottom line growth moved higher last quarter. Earnings were up 34%, compared to 32% in the prior report. Revenue increased from 23% to 24%.
Houlihan Lokey Cl A holds the No. 6 rank among its peers in the Finance-Investment Banking/Brokers industry group. Futu Holdings ADR, StoneX Group and LPL Financial Holdings are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
